Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Kilitch Drugs(I) Ltd.
₹141.80
₹137.00
₹152.20
₹293.53
₹500.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 44.67 | 37.81 | 34.12 | 56.30 | 46.51 |
| Operating Expense | 38.95 | 34.14 | 30.55 | 42.40 | 38.40 |
| Operating Profit | 5.72 | 3.67 | 3.57 | 13.91 | 8.12 |
| Depreciation | 0.56 | 0.53 | 0.50 | 0.51 | 0.47 |
| Interest | 0.60 | 0.68 | 0.59 | 0.72 | 0.49 |
| Tax | 1.28 | 1.36 | 1.19 | 3.62 | 2.64 |
| Net Profit | 4.89 | 8.72 | 4.79 | 11.37 | 6.88 |
₹141.80
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 69.2 | 69.2 | 69.2 | 69.2 | 63.8 | 63.8 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 30.8 | 30.8 | 30.8 | 30.8 | 36.2 | 36.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 40.46 K | 52.94 K | 76.43% |
| Week | 25.52 K | 39.2 K | 65.10% |
| 1 Month | 12.49 K | 19.42 K | 64.31% |
| 6 Month | 14.24 K | 27.68 K | 51.44% |
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Mid-range Performer (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 20 Sep, 2019 | 0.5 | FINAL | Equity Share | |
| 18 Sep, 2018 | 0.5 | FINAL | Equity Share | |
| 24 Sep, 2012 | 30 | SPECIAL | 25 Sep, 2012 | Equity Share |
| 18 Aug, 2011 | 1 | FINAL | Equity Share | |
| 14 Oct, 2010 | 1 | FINAL | 15 Oct, 2010 | Equity Share |
| 10 Sep, 2009 | 1 | FINAL | Equity Share | |
| 10 Sep, 2008 | 1 | FINAL | Equity Share | |
| 15 Nov, 2007 | 1 | INTERIM | 16 Nov, 2007 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹5.55 | ₹100.76 | ₹115 | ₹507 | ₹788 | ₹680 |
| % Change | -4.97% | 2.18% | -1.01% | -2.35% | 0.92% | -4.43% |
| Revenue TTM (₹ Cr) | ₹83.60 | ₹282.74 | - | ₹488.20 | ₹588.52 | ₹1,496.96 |
| Net Profit TTM (₹ Cr) | ₹-34.95 | ₹15.30 | - | ₹56.90 | ₹101.60 | ₹132.41 |
| PE TTM | -1.30 | 25.00 | - | 25.90 | 35.40 | 30.80 |
| 1 Year Return | 455 | -21.74 | 27.66 | -17.02 | 31.96 | -20.7 |
| ROCE | -5.63 | - | - | 23.87 | 9.34 | 14.12 |
Valiant Laboratories Ltd.
₹ 53.95
-5.07%
Supriya Lifescience Ltd.
₹ 586.00
-1.11%
Sigachi Industries Ltd.
₹ 18.21
-2.78%
Windlas Biotech Ltd.
₹ 759.50
-2.65%
Vineet Laboratories Ltd.
₹ 30.00
+1.49%
Solara Active Pharma Sciences Ltd.
₹ 440.90
-3.45%
Zim Laboratories Ltd.
₹ 63.50
-0.39%
Medico Remedies Ltd.
₹ 33.75
-6.33%
Dishman Carbogen Amcis Ltd.
₹ 142.30
-7.63%
Lasa Supergenerics Ltd.
₹ 5.95
-7.32%
Advanced Enzyme Technologies Ltd.
₹ 265.50
-3.28%
Bajaj Healthcare Ltd.
₹ 298.80
-4.81%
Ortin Global Ltd.
₹ 13.98
-4.96%
Brooks Laboratories Ltd.
₹ 43.19
-7.67%
RPG Life Sciences Ltd.
₹ 1856.00
-3.41%
Bafna Pharmaceuticals Ltd.
₹ 118.44
+0.61%
Alpa Laboratories Ltd.
₹ 51.10
-9.84%
Sun Pharma Advanced Research Company Ltd.
₹ 119.00
-9.47%
SMS Pharmaceuticals Ltd.
₹ 385.75
-4.65%
Nectar Lifesciences Ltd.
₹ 9.78
-4.96%
Mangalam Drugs and Organics Ltd.
₹ 28.46
-4.88%
Indoco Remedies Ltd.
₹ 173.28
-6.79%
Ind-Swift Laboratories Ltd.
₹ 138.30
+1.04%
Lincoln Pharmaceuticals Ltd.
₹ 585.00
-2.13%
By signing up I certify terms, conditions & privacy policy